Covid-19: DHSC: NHSX — Remote Symptoms Tracking System, App and Supply of SpO2 Devices
A Contract Award Notice
by DEPARTMENT OF HEALTH AND SOCIAL CARE
- Source
- OJEU
- Type
- Contract (Supply)
- Duration
- not specified
- Value
- £282K
- Sector
- HEALTH
- Published
- 12 Mar 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
London
3 buyers
1 supplier
- Huma Therapeutics London
Description
This procurement was awarded in April 2020 for access to the ‘Medopad software as a service and Application’ for a pilot in two London NHS Trusts. The supplier was selected as they hold the IPR or provision of their remote system, mobile application. This was provided pro bono for the period 20 April 2020 to 31 December 2020 inclusive. However, DHSC had to purchase 20 000 Pulse Oximeters at pace to allocate to the Pilot's patients, and these were in short supply and high demand in April 2020, as a number of countries were rolling out a similar pilot scheme. DHSC agreed one-off supply contract for these Pulse Oximeters via Huma's supply chain to ensure stock was available immediately, and configured to meet the Pilot's specification.
Total Quantity or Scope
A programme to deploy remote monitoring of Covid patients NHSX was reviewing the deployment of remote monitoring to ensure that patients have access to medical care during the Covid-19 pandemic. Medopad (owned by Huma Therapeutics Ltd) is a remote monitoring product that had completed the Digital Health London accelerator, and had approached NHSX (following the national call for innovator assistance) following their similar work with other EU governments, as part of their Covid19 response. The two use cases is for this programme of work were to perform daily monitoring on the Covid-19 patients that had been recently discharged from hospital and provide an electronic monitoring of potential Covid-19 patients who were routed through primary care hot hubs. Both use cases allowed the early identification of deterioration of patients and ensure that health professionals could intervene before their patients found it difficult to breath and had long lasting damage to their lungs. This procurement was for access to the ‘Medopad software as a service and Application’ for a pilot in two London NHS Trusts. … However, DHSC had to purchase 20 000 Pulse Oximeters at pace to allocate to the Pilot's patients and these were in short supply and high demand in April 2020, as a number of countries were rolling out a similar pilot scheme. DHSC agreed one-off supply contract for these Pulse Oximeters via Huma's supply chain to ensure stock was available immediately, and configured to meet the Pilot's specification..
Award Detail
1 | Huma Therapeutics (London)
|
Award Criteria
PRICE | _ |
CPV Codes
- 33195000 - Patient-monitoring system
- 48180000 - Medical software package
Indicators
- Award on basis of price.
Legal Justification
The Government must protect the health and well-being of UK citizens. The Covid-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 January 2020. The WHO Director General characterised Covid-19 as a pandemic on 11 March 2020. Covid-19 is serious and its consequences pose a risk to life. Cabinet Office published PPN 01/20: Responding to Covid-19 on procuring with extreme urgency in March 2020 which states that contracting authorities may enter into contracts without competing or advertising the requirement where certain tests are met. 1) There are genuine reasons for extreme urgency as there is a significant public health risk requiring immediate action as a result of Covid-19. 2) The Covid-19 situation is novel and the contracting authority could not have reasonably foreseen these events. 3) It is not possible to comply with the timescales of another procedure due to the urgent requirement to obtain the (supplies) being contracted for. Additionally, there are many buyers competing for the same supplies. It is imperative that security of supply is maintained. Demand for equipment is high and there is little or no incentive for suppliers to participate in competitive procurement procedures. 4) The situation is not attributable to the contracting authority. This procurement was awarded in April 2020 for access to the ‘Medopad software as a service and Application’ for a pilot in two London NHS Trusts. The supplier was selected as they hold the IPR or provision of their remote system, mobile application. This was provided pro bono for the period 20 April 2020 to 31 December 2020 inclusive. However, DHSC had to purchase 20 000 Pulse Oximeters at pace to allocate to the Pilot's patients, and these were in short supply and high demand in April 2020, as a number of countries were rolling out a similar pilot scheme. DHSC agreed one-off supply contract for these Pulse Oximeters via Huma's supply chain to ensure stock was available immediately, and configured to meet the Pilot's specification.
Other Information
A copy of the redacted contract is provided at the following link https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kHb2/6dYIxgutqoH... A copy of the redacted contract is provided at the following link https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kHb2/6dYIxgutqoH...
Reference
- OJEU 127223-2021